Potentiation of in vitro and in vivoantitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells
© Rathos et al.; licensee BioMed Central Ltd. 2013
Received: 13 September 2012
Accepted: 16 January 2013
Published: 23 January 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|13 Sep 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|17 Dec 2012||Author responded||Author comments - kalpana joshi|
|Resubmission - Version 3|
|17 Dec 2012||Submitted||Manuscript version 3|
|16 Jan 2013||Editorially accepted|
|23 Jan 2013||Article published||10.1186/1471-2407-13-29|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.